Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-01 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.370 | -0.640 | -0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
DYN | Dyne Therapeutics | 15.60 | -0.10 | -0.64% | 802.7M |
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
There are no as such competitors for Dyne Therapeutics.
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by JP Morgan on 2020-10-12. The analyst firm set a price target for 27.00 expecting DYN to rise to within 12 months (a possible 73.08% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $15.6 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Dyne Therapeutics.
There is no upcoming split for Dyne Therapeutics.